Differences between revisions 6 and 7
Revision 6 as of 2013-07-02 04:02:12
Size: 10569
Editor: jbarhak
Comment:
Revision 7 as of 2013-07-02 04:07:02
Size: 10136
Editor: jbarhak
Comment:
Deletions are marked like this. Additions are marked like this.
Line 44: Line 44:
 - There is a pressing need to utilize computational modeling & simulation to support clinical research and decision making in healthcare.

 - There is a gap in mechanisms or processes for translating computational models to the clinical practice.

* Research diversity
- Within and across mathematical and biological disciplines, subject matter experts tend to have their own interpretation of credibility assessment.

- Tools and good practice recommendations do not readily transfer across disciplines or are not adopted by different fields.
 - There is a pressing need to utilize computational modeling & simulation to support clinical research and decision making in healthcare. - There is a gap in mechanisms or processes for translating computational models to the clinical practice.
 * Research diversity - Within and across mathematical and biological disciplines, subject matter experts tend to have their own interpretation of credibility assessment. - Tools and good practice recommendations do not readily transfer across disciplines or are not adopted by different fields.
Line 55: Line 48:
 * Challenges of multiscale analysis

- Multiscale simulations require re-use of subsidiary models, which may have varying (or unknown) credibility.

- Propagation of uncertainties of a given scale for multiscale analysis can be complicated.
 * Challenges of multiscale analysis - Multiscale simulations require re-use of subsidiary models, which may have varying (or unknown) credibility. - Propagation of uncertainties of a given scale for multiscale analysis can be complicated.
Line 62: Line 50:
Line 64: Line 51:

 - verification & validation

 - uncertainty estimation

 - error propagation

 - evidence based assessment

 - reporting recommendations

 - model exchange and dissemination

 - standards and mark-up development

 - documentation


NEED
 - verification & validation - uncertainty estimation - error propagation - evidence based assessment - reporting recommendations - model exchange and dissemination - standards and mark-up development - documentation
'''NEED'''
Line 86: Line 56:

CHARGE
'''CHARGE'''
Line 90: Line 59:
Line 92: Line 60:
Line 94: Line 61:
Line 96: Line 62:


CHARGE
Line 102: Line 64:
 * Clearly describe committee's understanding of modeling and simulation vocabulary, e.g.,

 - model

 - simulation

 - multiscale

- verification

 - validation

 - uncertainty

 - sensitivity

- credibility

 - accreditation
 * Clearly describe committee's understanding of modeling and simulation vocabulary, e.g., - model - simulation - multiscale - verification - validation - uncertainty - sensitivity - credibility - accreditation
Line 123: Line 66:
Line 125: Line 67:

Line 129: Line 69:
 * Identify translational research directions to leverage readily available techniques to increase credibility of modeling and simulation in healthcare, e.g.,

- verification and validation

- uncertainty quantification

? Establish guidelines to implement readily available model evaluation techniques which are aware of the constraints of clinical practice

? Define novel translational workflows to enhance credibility of models and simulation processes


CHARGE
 * Identify translational research directions to leverage readily available techniques to increase credibility of modeling and simulation in healthcare, e.g., - verification and validation - uncertainty quantification ? Establish guidelines to implement readily available model evaluation techniques which are aware of the constraints of clinical practice ? Define novel translational workflows to enhance credibility of models and simulation processes
Line 145: Line 73:
Line 147: Line 74:
Line 149: Line 75:

CHARGE
Line 154: Line 77:
 * Bridge synergistic activities of establishing confidence in simulation-based medicine conducted by  * Bridge synergistic activities of establishing confidence in simulation-based medicine conducted by - modeling and simulation communities - scientific societies - clinical practitioners - regulatory agencies
 * Outreach to advocate credible practice of modeling and simulation through increased awareness and training; by providing - webinars - lectures - guidelines
'''ORGANIZATION'''
Line 156: Line 81:
 - modeling and simulation communities

 - scientific societies

 - clinical practitioners

 - regulatory agencies

 * Outreach to advocate credible practice of modeling and simulation through increased awareness and training; by providing

 - webinars

 - lectures

 - guidelines



ORGANIZATION

COMMITTEE Co-Chairs & Members: EXECUTE & CHARGE

ADVISORY COUNCIL: REVIEW & ADVISE
 * COMMITTEE Co-Chairs & Members: EXECUTE & CHARGE
 * ADVISORY COUNCIL: REVIEW & ADVISE
Line 184: Line 87:
ACTIVITY CYCLE: *** TBD IMAGE should go here ACTIVITY CYCLE:

attachment:ActivityCycle.jpg
Line 193: Line 98:

* Assign tasks to Committee Members to realize charge of the Committee and incorporate their work to reach Committee end-products

- Serve as Committee Members, i.e., take on and fulfill assigned tasks to realize charge of the Committee

- Report to Advisory Council and implement their feedback

- Report to IMAG/MSM and implement their feedback

- Evaluate performance of Committee Members

- Evaluate performance of Advisory Council

- Share authority and responsibilities equally

 * Assign tasks to Committee Members to realize charge of the Committee and incorporate their work to reach Committee end-products - Serve as Committee Members, i.e., take on and fulfill assigned tasks to realize charge of the Committee - Report to Advisory Council and implement their feedback - Report to IMAG/MSM and implement their feedback - Evaluate performance of Committee Members - Evaluate performance of Advisory Council - Share authority and responsibilities equally
Line 211: Line 101:
 * Committee Members (10 including Co-Chairs)

- Complete assigned tasks (on schedule) to realize charge of the Committee and prepare Committee end-products

- Report to the Committee and implement their feedback

- Represent a particular discipline and an area of practice to diversify Committee interests and reach out

- Evaluate performance of Committee Co-Chairs

- Evaluate performance of Advisory Council

- Expect to invest 8 hours of effort per month

 * Committee Members (10 including Co-Chairs) - Complete assigned tasks (on schedule) to realize charge of the Committee and prepare Committee end-products - Report to the Committee and implement their feedback - Represent a particular discipline and an area of practice to diversify Committee interests and reach out - Evaluate performance of Committee Co-Chairs - Evaluate performance of Advisory Council - Expect to invest 8 hours of effort per month
Line 228: Line 104:
 * Advisory Council

- Review Committee activities (on schedule) and provide feedback on the pathway for realization of the charge of the Committee and for preparation of Committee end-products

- Represent a particular discipline and an area of practice to broaden Committee affairs and reach out

- Evaluate performance of Committee Co-Chairs

- Evaluate performance of Committee Members

- Expect to invest 1 hour of effort per month

 * Advisory Council - Review Committee activities (on schedule) and provide feedback on the pathway for realization of the charge of the Committee and for preparation of Committee end-products - Represent a particular discipline and an area of practice to broaden Committee affairs and reach out - Evaluate performance of Committee Co-Chairs - Evaluate performance of Committee Members - Expect to invest 1 hour of effort per month
Line 246: Line 110:
Line 248: Line 111:
Line 250: Line 112:
Line 252: Line 113:
Line 254: Line 114:

* First-term (04/2013- 04/2015) appointed via IMAG consensus

- Lealem Mulugeta (NASA, IMAG representative)

- Ahmet Erdemir (Cleveland Clinic, MSM-WG representative)

 * First-term (04/2013- 04/2015) appointed via IMAG consensus - Lealem Mulugeta (NASA, IMAG representative) - Ahmet Erdemir (Cleveland Clinic, MSM-WG representative)
Line 264: Line 117:
 Committee Members (10 including Co-Chairs)
 . Committee Members (10 including Co-Chairs)
Line 267: Line 119:
Line 269: Line 120:
Line 271: Line 121:

* Multidisciplinary background

- clinicians

- mathematicians

- biologists

- engineers

- statisticians

- computer scientists

- product developers


 * Multidisciplinary background - clinicians - mathematicians - biologists - engineers - statisticians - computer scientists - product developers
Line 294: Line 126:
 * Wide variety of groups

- IMAG representatives

- MSM working groups

- External representatives

- Professional Societies

- Regulatory Agencies

- Funding Agencies

 * Wide variety of groups - IMAG representatives - MSM working groups - External representatives - Professional Societies - Regulatory Agencies - Funding Agencies
Line 313: Line 131:
 * Participation through nomination and invitation

- 2 year term with possibility of reappointment

- Continuing membership subject to commitment to providing feedback in a timely manner

- Substantial experience and expertise in respective areas of interest

 * Participation through nomination and invitation - 2 year term with possibility of reappointment - Continuing membership subject to commitment to providing feedback in a timely manner - Substantial experience and expertise in respective areas of interest
Line 325: Line 135:
Line 327: Line 136:
Line 329: Line 137:
Line 331: Line 138:
Line 333: Line 139:

Line 340: Line 144:
Line 342: Line 145:
Line 344: Line 146:
Line 346: Line 147:
Line 348: Line 148:
Line 352: Line 151:
Line 354: Line 152:
Line 356: Line 153:
Line 358: Line 154:
Line 362: Line 157:
Line 366: Line 160:
Line 370: Line 163:
Line 374: Line 166:
Line 378: Line 169:
Line 380: Line 170:
Line 382: Line 171:
Line 386: Line 174:
Line 388: Line 175:


Line 393: Line 177:
Line 395: Line 178:
Line 405: Line 187:

Committee Presentation

This page will contain the up to date committee presentation. Discussions regarding the page can be found at the bottom of the page.

Committee on Credible Practice of Modeling & Simulation in Healthcare

prepared by

Committee Co-Chairs

Interagency Modeling and Analysis Group

Multiscale Modeling Consortium

April 12, 2013

https://simtk.org/home/cpms

DEFINITIONS

Credible Practice of Modeling & Simulation in Healthcare

dependable with a desired certainty level to guide research or support decision making within a prescribed application domain and intended use; establishing reproducibility & accountability

Credible Practice of Modeling & Simulation in Healthcare

any activity involving development, solution, interpretation and application of computational representation of biological, environmental and man-made systems and their interaction thereof

Credible Practice of Modeling & Simulation in Healthcare

specifically computational modeling; virtual representation of system(s) of interest in a usable form in order to provide descriptive and predictive metrics for timely and systematic exploration of the system(s)

Credible Practice of Modeling & Simulation in Healthcare

computational solution of models to quantify descriptive and predictive metrics of system(s) of interest; including related post-processing efforts to calculate these metrics from raw analysis results

Credible Practice of Modeling & Simulation in Healthcare

any activity involving development, maintenance, advancement, or administration of medical care; including research, diagnosis, risk assessment, prevention, therapy, rehabilitation, surgery, intervention design, and regulation

NEED

  • Clinical urgency

    - There is a pressing need to utilize computational modeling & simulation to support clinical research and decision making in healthcare. - There is a gap in mechanisms or processes for translating computational models to the clinical practice.

  • Research diversity - Within and across mathematical and biological disciplines, subject matter experts tend to have their own interpretation of credibility assessment. - Tools and good practice recommendations do not readily transfer across disciplines or are not adopted by different fields.

NEED

  • Challenges of multiscale analysis - Multiscale simulations require re-use of subsidiary models, which may have varying (or unknown) credibility. - Propagation of uncertainties of a given scale for multiscale analysis can be complicated.
  • Scattered activities

    - In modeling & simulation (M&S) world, a plethora of commendable yet unconnected scientific and community activities exist for - verification & validation - uncertainty estimation - error propagation - evidence based assessment - reporting recommendations - model exchange and dissemination - standards and mark-up development - documentation

NEED

None of us are experts in everything. We need to learn from each other. Credible practice of modeling and simulation in healthcare requires ongoing inclusive communications to establish adaptive workflows that can be utilized broadly.

CHARGE

  • Adopt a consistent terminology
  • Propose guidelines and procedures for credible practice
  • Demonstrate workflows for credible practice
  • Promote good practice

Adopt a consistent terminology

  • Clearly describe committee's understanding of modeling and simulation vocabulary, e.g., - model - simulation - multiscale - verification - validation - uncertainty - sensitivity - credibility - accreditation
  • Consistently use appropriate vocabulary for communication
  • Unify discipline-specific appreciation of modeling and simulation vocabulary

Propose guidelines and procedures for credible practice

  • Identify translational research directions to leverage readily available techniques to increase credibility of modeling and simulation in healthcare, e.g., - verification and validation - uncertainty quantification ? Establish guidelines to implement readily available model evaluation techniques which are aware of the constraints of clinical practice ? Define novel translational workflows to enhance credibility of models and simulation processes

Demonstrate workflows for credible practice

  • Summarize state-of-the-art by identifying examples in literature and in field practice for the development of model credibility assessment procedures
  • Conduct studies, ideally with proposed guidelines and procedures, for the implementation of credibility assessment procedures in modeling and simulation in healthcare
  • Disseminate examples of credibility assessment by providing a repository of case studies on the implementation of proposed guidelines and procedures for different types of M&S

Promote good practice

  • Bridge synergistic activities of establishing confidence in simulation-based medicine conducted by - modeling and simulation communities - scientific societies - clinical practitioners - regulatory agencies
  • Outreach to advocate credible practice of modeling and simulation through increased awareness and training; by providing - webinars - lectures - guidelines

ORGANIZATION

  • COMMITTEE Co-Chairs & Members: EXECUTE & CHARGE

  • ADVISORY COUNCIL: REVIEW & ADVISE

Interagency Modeling and Analysis Group (IMAG)

Multiscale Modeling Consortium (MSM)

ACTIVITY CYCLE:

attachment:ActivityCycle.jpg

ROLES & EXPECTATIONS

Committee Co-Chairs (2)

  • Provide leadership and guidance to the Committee
  • Assign tasks to Committee Members to realize charge of the Committee and incorporate their work to reach Committee end-products - Serve as Committee Members, i.e., take on and fulfill assigned tasks to realize charge of the Committee - Report to Advisory Council and implement their feedback - Report to IMAG/MSM and implement their feedback - Evaluate performance of Committee Members - Evaluate performance of Advisory Council - Share authority and responsibilities equally

ROLES & EXPECTATIONS

  • Committee Members (10 including Co-Chairs) - Complete assigned tasks (on schedule) to realize charge of the Committee and prepare Committee end-products - Report to the Committee and implement their feedback - Represent a particular discipline and an area of practice to diversify Committee interests and reach out - Evaluate performance of Committee Co-Chairs - Evaluate performance of Advisory Council - Expect to invest 8 hours of effort per month

ROLES & EXPECTATIONS

  • Advisory Council - Review Committee activities (on schedule) and provide feedback on the pathway for realization of the charge of the Committee and for preparation of Committee end-products - Represent a particular discipline and an area of practice to broaden Committee affairs and reach out - Evaluate performance of Committee Co-Chairs - Evaluate performance of Committee Members - Expect to invest 1 hour of effort per month

PARTICIPATION

Committee Co-Chairs (2)

  • Nominated and elected by the Committee Members and the Advisory Council
  • 2 year term with possibility of reappointment
  • Elections 6 months prior to end of term
  • Continuing post subject to commitment to leadership
  • Ideally, one from IMAG and the other from MSM
  • First-term (04/2013- 04/2015) appointed via IMAG consensus - Lealem Mulugeta (NASA, IMAG representative) - Ahmet Erdemir (Cleveland Clinic, MSM-WG representative)

PARTICIPATION

  • Committee Members (10 including Co-Chairs)
  • Participation through nomination and invitation
  • 2 year term with possibility of reappointment
  • Continuing membership subject to commitment to timely completion of tasks
  • Multidisciplinary background - clinicians - mathematicians - biologists - engineers - statisticians - computer scientists - product developers

PARTICIPATION

Committee Members (10 including Co-Chairs)

  • Wide variety of groups - IMAG representatives - MSM working groups - External representatives - Professional Societies - Regulatory Agencies - Funding Agencies

PARTICIPATION

Advisory Council

  • Participation through nomination and invitation - 2 year term with possibility of reappointment - Continuing membership subject to commitment to providing feedback in a timely manner - Substantial experience and expertise in respective areas of interest

FIRST-TERM (2013-2015) GOALS

  • Form the Committee and the Advisory Council
  • Establish infrastructure for communications between Committee Co-Chairs and Members, and Advisory Council
  • Establish a web-based framework for development, community interactions, and dissemination
  • Develop a guidance document on establishing credible practice of modeling and simulation in healthcare
  • Draft a proposed model certification process

FIRST-TERM (2013-2015) TIMELINE

by April 30, 2013

  • Establish communication infrastructure
  • Establish web-based framework
  • Appoint Committee Members
  • Introductory meeting with Committee Members
  • Discuss objectives, roles & assign tasks

by May 31, 2013

  • Meeting with Committee Member to review first set of tasks
  • Appoint Advisory Council
  • Introductory meeting with Advisory Council
  • Discuss objectives, roles & summarize progress

by June 30, 2013

  • Working outline of guidance document

by MSM 2013 meeting

  • Community outreach to summarize progress and plans

by April 30, 2014

  • First draft of guidance document for external review

by October 31, 2014

  • Release of guidance document

by November 30, 2014

  • Journal article/white paper based on guidance document
  • Outline of model certification process
  • Co-Chairs; nominations and election

through December 2014 – April 2015

  • Co-Chairs; transition
  • First draft of proposed model certification process

CONTACT

CHECK https://simtk.org/home/cpms

Lealem Mulugeta

Committee Co-Chair

mulugeta@dsls.usra.edu

lealem.mulugeta@nasa.gov

Ahmet Erdemir

Committee Co-Chair

erdemira@ccf.org

Committee Presentation (last edited 2016-05-04 22:03:12 by localhost)